Led by Dr. James M. Wilson, the Gene Therapy Program at the University of Pennsylvania (GTP) focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. GTP strives to develop and commercialize transformative genetic-based therapeutics driven by the unmet needs of patients with inherited genetic diseases.